| Literature DB >> 33510247 |
Paul Middleton1, Pablo N Perez-Guzman2, Alexandra Cheng1, Naveenta Kumar1, Mara D Kont2, Anna Daunt1, Sujit Mukherjee1, Graham Cooke1,2,3, Timothy B Hallett2, Katharina Hauck2,4, Peter J White2,4,5, Mark R Thursz1, Shevanthi Nayagam6,7.
Abstract
Patients with strong clinical features of COVID-19 with negative real time polymerase chain reaction (RT-PCR) SARS-CoV-2 testing are not currently included in official statistics. The scale, characteristics and clinical relevance of this group are not well described. We performed a retrospective cohort study in two large London hospitals to characterize the demographic, clinical, and hospitalization outcome characteristics of swab-negative clinical COVID-19 patients. We found 1 in 5 patients with a negative swab and clinical suspicion of COVID-19 received a clinical diagnosis of COVID-19 within clinical documentation, discharge summary or death certificate. We compared this group to a similar swab positive cohort and found similar demographic composition, symptomology and laboratory findings. Swab-negative clinical COVID-19 patients had better outcomes, with shorter length of hospital stay, reduced need for > 60% supplementary oxygen and reduced mortality. Patients with strong clinical features of COVID-19 that are swab-negative are a common clinical challenge. Health systems must recognize and plan for the management of swab-negative patients in their COVID-19 clinical management, infection control policies and epidemiological assessments.Entities:
Mesh:
Year: 2021 PMID: 33510247 PMCID: PMC7844285 DOI: 10.1038/s41598-021-81930-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379